Lysine methylation goes global

Cell Cycle

Volumn 5, Issue 12, 2006, Pages 1308-1312

  Morgunkova, Anna ^a   Barlev, Nick A ^b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Chromatin; Gene regulation; Histone code; Lysine methylation; p53; Post translational modifications

Indexed keywords

ACYLTRANSFERASE; HISTONE; HISTONE METHYLTRANSFERASE; LYSINE; LYSINE METHYLTRANSFERASE; METHYLTRANSFERASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CHROMATIN; DEMETHYLATION; GENE CONTROL; HISTONE CODE; METHYLATION; PHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 33745122241     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.12.2820     Document Type: Review

References (65)

1. Downward J. The ins and outs of signalling. Nature 2001; 411:759-62.
2. Byvoet P. In vivo turnover and distribution of radio-N-methyl in arginine-rich histones from rat tissues. Arch Biochem Biophys 1972; 152:887-8.
3. Duerre JA, Lee CT. In vivo methylation and turnover of rat brain histones. J Neurochem 1974; 23:541-7.
4. von Holt C. Histones in perspective. Bioessays 1985; 3:120-4.
5. Su IH, Tarakhovsky A. Lysine methylation and 'signaling memory'. Curr Opin Immunol 2006; 18:152-7.
6. Polevoda B, Martzen MR, Das B, Phizicky EM, Sherman F. Cytochrome c methyltransferase, Ctm1p, of yeast. J Biol Chem 2000; 275:20508-13.
7. Kluck RM, Ellerby LM, Ellerby HM, Naiem S, Yaffe MP, Margoliash E, Bredesen D, Mauk AG, Sherman F, Newmeyer DD. Determinants of cytochrome c pro-apoptotic activity. The role of lysine 72 trimethylation. J Biol Chem 2000; 275:16127-33.
8. Kruiswijk T, Kunst A, Planta RJ, Mager WH. Modification of yeast ribosomal proteins. Methylation. Biochem J 1978; 175:221-5.
9. Lee SW, Berger SJ, Martinovic S, Pasa-Tolic L, Anderson GA, Shen Y, Zhao R, Smith RD. Direct mass spectrometric analysis of intact proteins of the yeast large ribosomal subunit using capillary LC/FTICR. Proc Natl Acad Sci USA 2002; 99:5942-7.
10. Porras-Yakushi TR, Whitelegge JP, Miranda TB, Clarke S. A novel SET domain methyltransferase modifies ribosomal protein Rpl23ab in yeast. J Biol Chem 2005; 280:34590-8.
11. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074-80.
12. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403:41-5.
13. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 2002; 12:198-209.
14. Bannister AJ, Schneider R, Kouzarides T. Histone methylation: Dynamic or static? Cell 2002; 109:801-6.
15. Bannister AJ, Kouzarides T. Reversing histone methylation. Nature 2005; 436:1103-6.
16. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6:838-49.
17. Yang XJ. Multisite protein modification and intramolecular signaling. Oncogene 2005; 24:1653-62.
18. Pray-Grant MG, Daniel JA, Schieltz D, Yates IIIrd JR, Grant PA. Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 2005; 433:434-8.
19. Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, Burlingame AL, Roeder RG, Brivanlou AH, Allis CD. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 2005; 121:859-72.
20. Sims IIIrd RJ, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS, Reinberg D. Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem 2005; 280:41789-92.
21. Daniel JA, Pray-Grant MG, Grant PA. Effector proteins for methylated histones: An expanding family. Cell Cycle 2005; 4:919-26.
22. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001; 410:116-20.
23. Lachner M, Jenuwein T. The many faces of histone lysine methylation. Curr Opin Cell Biol 2002; 14:286-98.
24. Schneider R, Bannister AJ, Kouzarides T. Unsafe SETs: Histone lysine methyltransferases and cancer. Trends Biochem Sci 2002; 27:396-402.
25. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001; 8:1207-17.
26. Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P, Reinberg D. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 2002; 16:479-89.
27. Xiao B, Jing C, Wilson JR, Walker PA, Vasisht N, Kelly G, Howell S, Taylor IA, Blackburn GM, Gamblin SJ. Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 2003; 421:652-6.
28. Chuikov S, Kurash Y, Wilson JR, Xiao B, Justin N, Ivanov G, McKinney K, Tempst P, Prives C, Gamblin S, Barlev N, Reinberg D. Regulation of p53 activity through lysine methylation. Nature 2004; 432:353-60.
29. Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 2004; 14:175-82.
30. Couture JF, Collazo E, Hauk G, Trievel RC. Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol 2006; 13:140-6.
31. Bell B, Tora L. Regulation of gene expression by multiple forms of TFIID and other novel TAFII-containing complexes. Exp Cell Res 1999; 246:11-9.
32. Muller F, Tora L. The multicoloured world of promoter recognition complexes. EMBO J 2004; 23:2-8.
33. Mohan Jr WS, Scheer E, Wendling O, Metzger D, Tora L. TAF10 (TAF(II)30) is necessary for TFIID stability and early embryogenesis in mice. Mol Cell Biol 2003; 23:4307-18.
34. Gegonne A, Weissman JD, Singer DS. TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. Proc Natl Acad Sci USA 2001; 98:12432-7.
35. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 268:2764-72.
36. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: The molecular basis for p53 regulation. Curr Opin Cell Biol 2003; 15:164-71.
37. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4:793-805.
38. Kobet E, Zeng X, Zhu Y, Keller D, Lu H. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. Proc Natl Acad Sci USA 2000; 97:12547-52.
39. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9.
40. Brooks CL, Gu W. p53 Ubiquitination: Mdm2 and beyond. Mol Cell 2006; 21:307-15.
41. Li M, Luo J, Brooks CL, Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 2002; 277:50607-11.
42. Brooks CL, Li M, Gu W. Monoubiquitination: The signal for p53 nuclear export? Cell Cycle 2004; 3:436-8.
43. Zegerman P, Canas B, Pappin D, Kouzarides T. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem 2002; 277:11621-4.
44. Fischle W, Wang Y, Allis CD. Binary switches and modification cassettes in histone biology and beyond. Nature 2003; 425:475-9.
45. Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu JY, Allis CD, Marmorstein R, Berger L. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Molecular Cell 2000; 5:917-26.
46. Lo WS, Gamache ER, Henry KW, Yang D, Pillus L, Berger SL. Histone H3 phosphorylation can promote TBP recruitment through distinct promoter-specific mechanisms. EMBO J 2005; 24:997-1008.
47. Youmell M, Park SJ, Basu S, Price BD. Regulation of the p53 protein by protein kinase C alpha and protein kinase C zeta. Biochem Biophys Res Commun 1998; 245:514-8.
48. Zhang K, Lin W, Latham JA, Riefler GM, Schumacher JM, Chan C, Tatchell K, Hawke DH, Kobayashi R, Dent SY. The Set1 methyltransferase opposes Ipl1 aurora kinase functions in chromosome segregation. Cell 2005; 122:723-34.
49. Courtwright AM, He X. Dam1 is the right one: Phosphoregulation of kinetochore biorientation. Dev Cell 2002; 3:610-1.
50. Hess JL. Mechanisms of transformation by MLL. Crit Rev Eukaryot Gene Expr 2004; 14:235-54.
51. Tenney K, Shilatifard A. A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: Linking leukemogensis to covalent modifications of chromatin. J Cell Biochem 2005; 95:429-36.
52. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119:941-53.
53. Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437:432-5.
54. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439:811-6.
55. Wysocka J, Milne TA, Allis CD. Taking LSD 1 to a new high. Cell 2005; 122:654-8.
56. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437:436-9.
57. Clissold PM, Ponting CP. JmjC: Cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. Trends Biochem Sci 2001; 26:7-9.
58. Cha TL, Zhou BP, Xia W, Wu Y, Yang CC, Chen CT, Ping B, Otte AP, Hung MC. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 2005; 310:306-10.
59. Chakraborty S, Sinha KK, Senyuk V, Nucifora G. SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo. Oncogene 2003; 22:5229-37.
60. Zhang K, Dent SY. Histone modifying enzymes and cancer: Going beyond histones. J Cell Biochem 2005; 96:1137-48.
61. Su IH, Dobenecker MW, Dickinson E, Oser M, Basavaraj A, Marqueron R, Viale A, Reinberg D, Wulfing C, Tarakhovsky A. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 2005; 121:425-36.
62. Martin C, Cao R, Zhang Y. Substrate preferences of the EZH2 histone methyltransferase complex. J Biol Chem 2006; 281:8365-70.
63. Houtz RL, Stults JT, Mulligan RM, Tolbert NE. Post-translational modifications in the large subunit of ribulose bisphosphate carboxylase/ oxygenase. Proc Natl Acad Sci USA 1989; 86:1855-9.
64. Roguev A, Schaft D, Shevchenko A, Pijnappel WW, Wilm M, Aasland R, Stewart AF. The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4. EMBO J 2001; 20:7137-48.
65. Odintsova TI, Muller EC, Ivanov AV, Egorov TA, Bienert R, Vladimirov SN, Kostka S, Otto A, Wittmann-Liebold B, Karpova GG. Characterization and analysis of posttranslational modifications of the human large cytoplasmic ribosomal subunit proteins by mass spectrometry and Edman sequencing. J Protein Chem 2003; 22:249-58.